Patents by Inventor Hyeon Jeong LEE

Hyeon Jeong LEE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOUND FOR CAPPING LAYER AND ORGANIC LIGHT EMITTING DEVICE INCLUDING SAME
    Publication number: 20240158338
    Abstract: A novel compound for a capping layer, and an organic light-emitting device containing the same are disclosed.
    Type: Application
    Filed: December 29, 2023
    Publication date: May 16, 2024
    Inventors: Ho Wan HAM, Hyun Cheol AN, Hee Joo KIM, Dong Jun KIM, Ja Eun ANN, Dong Yuel KWON, Sung Kyu LEE, Hwan Il JE, Bo Ra LEE, Yeong Rong PARK, Il Soo OH, Dae Woong LEE, Hyeon Jeong IM, Ill Hun CHO
  • COMPOUND FOR CAPPING LAYER AND ORGANIC LIGHT EMITTING DEVICE INCLUDING SAME
    Publication number: 20240164138
    Abstract: A novel compound for a capping layer, and an organic light-emitting device containing the same are disclosed.
    Type: Application
    Filed: December 29, 2023
    Publication date: May 16, 2024
    Inventors: Ho Wan HAM, Hyun Cheol AN, Hee Joo KIM, Dong Jun KIM, Ja Eun ANN, Dong Yuel KWON, Sung Kyu LEE, Tae Jin LEE, Bo Ra LEE, Yeong Rong PARK, Il Soo OH, Dae Woong LEE, Hyeon Jeong IM, Ill Hun CHO
  • PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING OBESITY OR NON-ALCOHOLIC FATTY LIVER, CONTAINING DENTAL TISSUE-DERIVED MULTIPOTENT STEM CELLS
    Publication number: 20220339196
    Abstract: The present invention relates to a pharmaceutical composition for preventing or treating obesity or non-alcoholic fatty liver, containing dental tissue-derived mesenchymal stem cells cryopreserved by vitrification. The pharmaceutical composition for preventing or treating obesity or non-alcoholic fatty liver, of the present invention, reduces body weight, lowers serum adipokine concentration, allows the liver to recover in view of histological findings, and improves lipid metabolic enzymes in the liver, thereby exhibiting remarkable prevention and treatment effects on obesity or non-alcoholic fatty liver. In addition, dental tissue-derived mesenchymal stem cells, which are the active ingredients of the present invention, are mesodermal stem cells having verified safety and may be obtained with the least invasiveness, and thus are expected to be effectively used as a cell therapeutic agent for obesity or non-alcoholic fatty liver.
    Type: Application
    Filed: September 7, 2020
    Publication date: October 27, 2022
    Inventors: Gyu Jin Rho, Kyung Min Kim, Si Jung Jang, Sung Lim Lee, Bong Wook Park, Hyeon Jeong Lee
  • SUSPENDED FLOWERPOT ADAPTED TO AUTOMATIC WATER SUPPLY
    Publication number: 20210161087
    Abstract: The present invention relates to a suspended flowerpot adapted to automatic water supply and, more specifically, to a plant cultivation system wherein multiple flowerpots can be suspended on a horizontal member, and the system has a water supply structure enabling automatic water supply to the flowerpots by means of buoyancy, thereby facilitating management for plant cultivation.
    Type: Application
    Filed: July 24, 2019
    Publication date: June 3, 2021
    Applicant: AGRICULTURAL CORPORATION GYERYONGCHIU AGRICULTURAL CO., LTD.
    Inventor: Hyeon Jeong LEE